HRT FINANCIAL LP

Position in BSX — Boston Scientific Corp

CIK 1475597 NEW YORK, NY

Position in BSX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$66,012,749

+$34,389,350 QoQ

Shares Held

1,051,996

+217.2% QoQ

Ownership

0.071%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $191,506,751 across 40 Medical Devices names. BSX ranks #1 (34.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp This page	1,051,996	$66,012,749
2	MASI	Masimo Corp	264,837	$47,106,557
3	BIO	Bio-Rad Laboratories, Inc.	46,556	$12,977,485
4	HAE	Haemonetics Corp	193,634	$10,913,212
5	BRKR	Bruker Corp	235,704	$8,513,628
6	PEN	Penumbra Inc	18,854	$6,191,087
7	ESTA	Establishment Labs Holdings Inc.	108,802	$6,177,777
8	IRMD	Iradimed Corp	47,537	$4,575,911

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$66,012,749	1,051,996	+217.2%	Shares	Defined	2026-05-14
2025-12-31	$31,623,399	331,656	-62.8%	Shares	Defined	2026-02-12
2025-09-30	$87,119,642	892,345	+164.6%	Shares	Defined	2025-11-14
2025-06-30	$36,226,170	337,270	+73.2%	Shares	Defined	2025-08-14
2025-03-31	$19,649,305	194,779	+421.9%	Shares	Defined	2025-05-15
2024-09-30	$3,127,416	37,320	-82.2%	Shares	Defined	2024-11-12
2024-06-30	$16,184,729	210,164	+2988.8%	Shares	Defined	2024-08-12
2024-03-31	$466,005	6,804	-98.5%	Shares	Defined	2024-05-13
2023-06-30	$24,779,494	458,116	+2563.5%	Shares	Defined	2023-08-11
2022-12-31	$795,844	17,200	-91.7%	Shares	Defined	2023-02-10
2022-03-31	$9,141,278	206,396	+53.4%	Shares	Defined	2022-05-16
2021-06-30	$5,753,700	134,558	+258.1%	Shares	Defined	2021-08-16
2020-03-31	$1,225,974	37,572	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.